UIH(SH:688271) Sou Hu Cai Jing·2026-01-06 11:56Core Viewpoint - The financial performance of United Imaging Healthcare (688271) shows significant growth in revenue and net profit, indicating strong operational efficiency and market demand for its medical imaging and treatment solutions [2]. Financial Performance - For the first three quarters of 2025, the company reported a main revenue of 8.859 billion yuan, an increase of 27.39% year-on-year [2]. - The net profit attributable to shareholders reached 1.12 billion yuan, up 66.91% year-on-year [2]. - The non-recurring net profit was 1.053 billion yuan, reflecting a substantial increase of 126.94% year-on-year [2]. - In Q3 2025 alone, the company achieved a main revenue of 2.843 billion yuan, a remarkable rise of 75.41% year-on-year [2]. - The net profit for Q3 was 122 million yuan, showing a 143.8% increase year-on-year [2]. - The non-recurring net profit for Q3 was 87.6141 million yuan, up 126.24% year-on-year [2]. - The company's debt ratio stands at 30.08%, with investment income of 606.847 million yuan and financial expenses of -438.233 million yuan, while the gross profit margin is 47.02% [2]. Market Activity - As of January 6, 2026, the stock price closed at 133.99 yuan, reflecting a 0.9% increase with a turnover rate of 0.91% and a trading volume of 75,300 hands, amounting to a total transaction value of 1.008 billion yuan [1]. - The net outflow of main funds was 48.8411 million yuan, accounting for 4.85% of the total transaction value, while retail investors saw a net inflow of 10.9375 million yuan, representing 1.09% of the total transaction value [1]. Analyst Ratings - In the last 90 days, 25 institutions have provided ratings for the stock, with 18 buy ratings and 7 hold ratings [2]. - The average target price set by institutions over the past 90 days is 17.312 billion yuan [2].